| 705118 |
SURGICAL NEUROLOGY INTERNATIONAL |
Intravenous versus inhalational anesthesia trial for outcome following intracranial aneurysm surgery: A prospective randomized controlled study |
2021-06-21 |
10.25259/sni_342_2021 |
Bhagat Hemant, Sharma Tanavi, Mahajan Shalvi, Kumar Munish, Saharan Poonam, Bhardwaj Avanish, Sachdeva Naresh, Gandhi Komal, Jangra Kiran, Panda Nidhi Bidyut, Singla Navneet, Kishore Kamal, Singh Nidhi |
| 705117 |
SURGICAL NEUROLOGY INTERNATIONAL |
Inflammatory myofibroblastic tumor masquerading as an anterior choroidal artery fusiform aneurysm |
2021-06-21 |
10.25259/sni_113_2021 |
Malnik Samuel Louis, Moor Rachel Freedman, Shin David, Laurent Dimitri, Trejo-Lopez Jorge, Dodd William, Yachnis Anthony, Ghiaseddin Ashley P., Fox W. Christopher, Roper Steven |
| 705116 |
SURGICAL NEUROLOGY INTERNATIONAL |
Heterologous spinal cord transplantation in man |
2021-06-21 |
10.25259/sni_395_2021 |
Canavero Sergio, Ren Xiaoping, Kim C-Yoon |
| 705115 |
SURGICAL NEUROLOGY INTERNATIONAL |
Infundibular hemangioblastoma resection: Video case report |
2021-06-21 |
10.25259/sni_288_2021 |
Housley Steven B., Recker Matthew J., O’Connor Timothy E., Siddiqui Adnan H. |
| 705114 |
RISK ANALYSIS : AN OFFICIAL PUBLICATION OF THE SOCIETY FOR RISK ANALYSIS |
Quantifying SARS‐CoV‐2 Infection Risk Within the Google/Apple Exposure Notification Framework to Inform Quarantine Recommendations |
2021-06-21 |
10.1111/risa.13768 |
Wilson Amanda M., Aviles Nathan, Petrie James I., Beamer Paloma I., Szabo Zsombor, Xie Michelle, McIllece Janet, Chen Yijie, Son Young‐Jun, Halai Sameer, White Tina, Ernst Kacey C., Masel Joanna |
| 705113 |
THE ONCOLOGIST |
Adjuvant Olaparib Improves Disease‐Free Survival in Early, High‐Risk , BRCA ‐Mutated , HER2 – Breast Cancer |
2021-06-21 |
10.1002/onco.13863 |
|
| 705112 |
THE ONCOLOGIST |
Ribociclib Shows Sustained Overall Survival Benefit in Postmenopausal Women with HR +/ HER2 – Advanced Breast Cancer |
2021-06-21 |
10.1002/onco.13866 |
|
| 705111 |
THE ONCOLOGIST |
Palbociclib Plus Fulvestrant Maintains Long‐Term Overall Survival Benefit in HR +/ HER2 – Advanced Breast Cancer |
2021-06-21 |
10.1002/onco.13864 |
|
| 705110 |
THE ONCOLOGIST |
Dalpiciclib Extends Progression‐Free Survival in HR +/ HER2 – Advanced Breast Cancer |
2021-06-21 |
10.1002/onco.13865 |
|
| 705109 |
THE ONCOLOGIST |
A Phase I Trial of Oxaliplatin, Irinotecan, and S‐1 Combination Therapy (
OX‐IRIS
) as Chemotherapy for Unresectable Pancreatic Cancer (
HGCSG
1403) |
2021-06-21 |
10.1002/onco.13838 |
Kawamoto Yasuyuki, Nakatsumi Hiroshi, Harada Kazuaki, Muranaka Tetsuhito, Ishiguro Atsushi, Kobayashi Yoshimitsu, Hayashi Hideyuki, Yuki Satoshi, Sawada Kentaro, Yagisawa Masataka, Nakano Shintar, Sakamoto Naoya, Komatsu Yoshito |
